Evidence-Based Medicine Guidelines
Endothelin receptor antagonists for pulmonary arterial hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451524/all/Endothelin_receptor_antagonists_for_pulmonary_arterial_hypertension.
Endothelin receptor antagonists for pulmonary arterial hypertension. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451524/all/Endothelin_receptor_antagonists_for_pulmonary_arterial_hypertension. Accessed April 23, 2025.
Endothelin receptor antagonists for pulmonary arterial hypertension. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451524/all/Endothelin_receptor_antagonists_for_pulmonary_arterial_hypertension
Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451524/all/Endothelin_receptor_antagonists_for_pulmonary_arterial_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Endothelin receptor antagonists for pulmonary arterial hypertension
ID - 451524
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451524/all/Endothelin_receptor_antagonists_for_pulmonary_arterial_hypertension
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
